Importance of Standardized Nomenclature to Advance Hidradenitis Suppurativa Research and Clinical Care
Published in JAMA dermatology
Burden of Ocular Comorbidities in Patients With Hidradenitis Suppurativa.
Published in JAMA dermatology
UV Exposure and the Risk of Cutaneous Melanoma in Skin of Color: A Systematic Review.
Published in JAMA dermatology
While current evidence supports UV exposure as an important risk factor for cutaneous melanoma in fair-skinned populations, the evidence for this association in skin of color is less certain. To critically assess and synthesize the published data regarding the association between UV exposure and the risk of cutaneous melanoma in skin of color. A se...
Rates of Vascular Occlusion Associated With Using Needles vs Cannulas for Filler Injection.
Published in JAMA dermatology
Soft-tissue augmentation with skin fillers can be delivered with needles or microcannulas, but unwanted vascular occlusions are possible. To determine whether filler-associated vascular occlusion events of the face occur more often with injections performed with needles than with microcannulas. This retrospective cohort study included a random samp...
Dermoscopy Proficiency Expectations for US Dermatology Resident Physicians: Results of a Modified Delphi Survey of Pigme...
...Published in JAMA dermatology
Dermoscopy education in US dermatology residency programs varies widely, and there is currently no existing expert consensus identifying what is most important for resident physicians to know. To identify consensus-based learning constructs representing an appropriate foundational proficiency in dermoscopic image interpretation for dermatology resi...
Linear Immunoglobulin-A Bullous Dermatosis.
Published in JAMA dermatology
Leonine Facies and Madarosis in a Man With Shortness of Breath.
Published in JAMA dermatology
Challenges and Controversy in Determining UV Exposure as a Risk Factor for Cutaneous Melanoma in Skin of Color.
Published in JAMA dermatology
Mucocutaneous Adverse Events Associated With Oral Sirolimus for the Treatment of Vascular Anomalies.
Published in JAMA dermatology
Association of Programmed Cell Death 1 Inhibitor With Circumorificial Plasmacytosis.
Published in JAMA dermatology
